U.S. Markets closed

Aemetis to Review Fourth Quarter and Year-End Financial Results on March 29, 2018

CUPERTINO, CA / ACCESSWIRE / March 20, 2018 / Aemetis, Inc. (AMTX) announced that the company will host a conference call to review the release of its fourth quarter and year-end 2017 earnings report:

Date: Thursday, March 29, 2018

Time: 11 am Pacific Time (PT)

Live Participant Dial In (Toll-Free): +1-877-407-8035

Live Participant Dial In (International): +1-201-689-8035

Webcast URL: www.investorcalendar.com/event/27138

Attendees may submit questions during the Q&A portion of the conference call.

After March 29th, the webcast will be available on the Company's website (www.aemetis.com) under Investors/Conference Calls. The voice recording will also be available through April 5, 2018 by dialing (Toll-Free) +1-877-481-4010 or (International) +1-919-882-2331 and entering conference ID number 27138.

About Aemetis

Headquartered in Cupertino, California, Aemetis is an advanced renewable fuels and biochemicals company focused on the acquisition, development and commercialization of innovative technologies that replace traditional petroleum-based products by the conversion of ethanol and biodiesel plants into advanced biorefineries. Founded in 2006, Aemetis owns and operates a 60 million gallon per year ethanol production facility in California's Central Valley, near Modesto. Aemetis also owns and operates a 50 million gallon per year renewable chemical and advanced fuel production facility on the East Coast of India producing high quality distilled biodiesel and refined glycerin for customers in India, the US and Europe. Aemetis operates a research and development laboratory and holds a portfolio of patents and related technology licenses for the production of renewable fuels and biochemicals. For additional information about Aemetis, please visit www.aemetis.com.

External Investor Relations Contact:
Kirin Smith
PCG Advisory Group
(646) 863-6519

Company Investor Relations/ Media Contact:
Todd Waltz
(408) 213-0940

SOURCE: Aemetis, Inc.